CATALOGO DEI PRODOTTI DELLA RICERCA

SENNA, Gianenrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.803
NA - Nord America 4.917
AS - Asia 4.207
SA - Sud America 664
AF - Africa 123
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 15.722
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.785
RU - Federazione Russa 2.974
SG - Singapore 1.871
CN - Cina 1.104
IT - Italia 728
GB - Regno Unito 588
BR - Brasile 532
HK - Hong Kong 446
VN - Vietnam 333
DE - Germania 315
FR - Francia 312
SE - Svezia 268
IE - Irlanda 259
FI - Finlandia 135
KR - Corea 122
IN - India 74
CA - Canada 65
JP - Giappone 56
MX - Messico 50
AR - Argentina 49
ID - Indonesia 37
NL - Olanda 37
BD - Bangladesh 36
ZA - Sudafrica 36
ES - Italia 34
TR - Turchia 32
UA - Ucraina 32
PL - Polonia 31
TG - Togo 26
BJ - Benin 25
AT - Austria 21
BE - Belgio 20
CO - Colombia 16
EC - Ecuador 16
VE - Venezuela 15
IQ - Iraq 14
CL - Cile 13
MA - Marocco 11
SA - Arabia Saudita 11
PY - Paraguay 10
LT - Lituania 9
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
CH - Svizzera 7
JO - Giordania 7
PK - Pakistan 7
UZ - Uzbekistan 7
KE - Kenya 6
NO - Norvegia 6
PE - Perù 6
UY - Uruguay 5
BG - Bulgaria 4
EG - Egitto 4
IL - Israele 4
JM - Giamaica 4
LB - Libano 4
NP - Nepal 4
SN - Senegal 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LV - Lettonia 3
MY - Malesia 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AU - Australia 2
BO - Bolivia 2
DM - Dominica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EU - Europa 2
LK - Sri Lanka 2
MG - Madagascar 2
PA - Panama 2
RO - Romania 2
YE - Yemen 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
DK - Danimarca 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
MD - Moldavia 1
ML - Mali 1
MZ - Mozambico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
Totale 15.712
Salva come PNG Salva come JPEG
Città #
Moscow 1.001
Singapore 898
Dallas 711
Chandler 626
Ashburn 478
Hong Kong 440
Southend 422
New York 279
Dublin 255
Beijing 250
The Dalles 162
Jacksonville 158
Woodbridge 145
Verona 133
Los Angeles 126
Lawrence 109
Princeton 109
Ho Chi Minh City 91
Wilmington 90
Munich 89
Houston 87
Hanoi 77
Ann Arbor 75
Sindelfingen 74
Buffalo 68
Jinan 60
Helsinki 53
Milan 53
Redondo Beach 53
Shenyang 53
London 52
São Paulo 52
Tokyo 50
Columbus 47
Nanjing 39
Rome 38
Redmond 37
Bologna 36
Denver 36
Hebei 36
Boardman 34
Guangzhou 34
Chennai 30
Turku 29
Warsaw 29
Brooklyn 28
Seattle 28
Johannesburg 27
Redwood City 27
Changsha 26
Ningbo 26
Santa Clara 26
Cotonou 25
Lomé 25
Poplar 25
Tianjin 25
Amsterdam 23
Kent 23
Haikou 22
Montreal 22
Nanchang 21
Norwalk 21
Stockholm 21
Dong Ket 20
Nuremberg 20
Rio de Janeiro 20
San Francisco 20
Haiphong 19
Taizhou 19
Toronto 19
Taiyuan 18
Brussels 17
Hangzhou 17
Naples 17
Orem 17
Zhengzhou 17
Council Bluffs 16
Mexico City 16
Falkenstein 15
Phoenix 15
Atlanta 14
Boston 14
Padova 14
Chicago 13
Jakarta 13
Ankara 12
Frankfurt am Main 12
Seoul 12
Curitiba 11
Da Nang 11
Lanzhou 11
Mumbai 11
Querétaro 11
Bari 10
Brasília 10
Jiaxing 10
Lappeenranta 10
Porto Alegre 10
San Jose 10
Vienna 10
Totale 8.776
Salva come PNG Salva come JPEG
Nome #
Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management 387
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 196
Safety of Biologic Therapies for Severe Asthma: An Analysis of Adverse Reactions Reported in the WHO Pharmacovigilance Database 184
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels 184
Fatal asthma; is it still an epidemic? 182
Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and hymenopteria allergy 181
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management 173
Study on the Immunoreactivity of Triticum monococcum (Einkorn) Wheat in Patients with Wheat-Dependent Exercise-Induced Anaphylaxis for the Production of Hypoallergenic Foods 167
Allergic rhinitis: pharmacotherapy in pregnancy and old age 166
Asthmatic patients in COVID-19 outbreak: Few cases despite many cases 166
La salute del respiro: epidemiologia, costi sanitari ed implicazioni sociali delle malattie respiratorie croniche in Europa e in Italia 164
Allergy and the bone: unexpected relationships 161
Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience 152
A double-blind placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjects 150
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 147
Asthma control in primary care: the results of an observational cross-sectional study in Italy and Spain 145
Adverse reaction to local anaesthetics: Is it always allergy? 145
Analysis of the positivity rate in IgE positive patients to inhalant allergens in Verona Hospital Laboratory during 2002-2003 141
Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma 139
Biologics for Eosinophilic Granulomatosis with Polyangiitis: one size does not fit all 139
Clinical response to biologicals for severe asthma: any relevance for sex in different age ranges? 137
Asthma under/misdiagnosis in primary care setting: an observational community-based study in Italy 137
Thunderstorm Asthma: A Critical Appraisal Based on Clinical Practice 135
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 135
Successful switching from mepolizumab to dupilumab in a patient with EGPA in remission phase and persistent nasal polyposis 134
Allergen Immunotherapy Adherence in the Real World: How Bad Is It and How Can It Be Improved? 132
Anaphylaxis and intimate behaviour 130
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 130
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 129
Periostin: The bone and beyond 128
COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control 128
Evaluation of asthma control in the pharmacy: an Italian cross-sectional study 127
Impatto socio-sanitario e livello del controllo delle patologie respiratorie croniche ostruttive e della rinite in Italia 125
Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study 125
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 124
Low‑dose anti‑IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance 122
Allergen-specific immunotherapy and COVID-19: What happened? 121
Biologics and global burden of asthma: A worldwide portrait and a call for action 120
ALLERGY AND CORONAVIRUS DISEASE (COVID-19) INTERNATIONAL SURVEY: REAL-LIFE DATA FROM THE ALLERGY COMMUNITY DURING THE PANDEMIC 118
Anaphylaxis and Coronavirus Disease 2019 vaccine: a danger relationship? 117
New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic 117
Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective 115
Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response 114
Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety 114
COPD prevalence in a north-eastern Italian general population 114
The potential role of local pharmacies to assess asthma control: an Italian cross-sectional study 113
Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach 111
Timing of response and long term efficacy of Omalizumab in non-clonal Mast Cell Activation Syndrome: A case series 111
Balancing efficacy against safety in sublingual immunotherapy with inhalant allergens: what is the best approach? 111
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 109
Systemic Reactions After Hymenoptera Sting And Raised Serum Tryptase Strongly Suggest Clonal Mast Cells Disorders 109
Is hymenoptera venom allergy an occupational disease? 108
Uncontrolled Asthma: Unmet Needs in the Management of Patients 108
Scombroid syndrome: it seems to be fish allergy but... it isn't 106
What lies beyond Asthma Control Test: Suggestions for clinical practice 104
Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics 103
Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia 103
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials 102
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report 101
Relevance of TH2 markers in the assessment and therapeutic management of severe allergic asthma: A real-life perspective 101
Asthma management among different specialists: results from a national Italian survey 101
Multidisciplinary management in type 2 inflammatory disease 100
Potential benefit of omalizumab in respiratory diseases 99
Comment on: Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma: reply 99
Adherence to Intranasal Steroids in Chronic Rhinosinusitis with Nasal Polyposis Prior to and during Biologic Therapy: A Neglected Matter 98
Omalizumab management beyond clinical trials: the added value of a network model 98
How much specific is the association between hymenoptera venom allergy and mastocytosis? 98
Safety of uSCIT-MPL-4: prevalence and risk factors of systemic reactions in real life 98
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly 96
Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy 96
Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort 96
Wasp venom allergy screening with recombinant allergen testing. Diagnostic performance of rPol d 5 and rVes v 5 for differentiating sensitization to Vespula and Polistes subspecies 95
Profiling blood hypereosinophilia in patients on dupilumab treatment for respiratory conditions: a real-life snapshot 94
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis 93
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 93
SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma 92
One-year mepolizumab for Allergic bronchopulmonary aspergillosis: Focus on steroid sparing effect and markers of response 92
A hierarchical cluster analysis of the psycological impact of the COVID-19 pandemic on Italian severe asthma patients 91
Diagnosis, management and therapeutic options for eosinophilic esophagitis 91
IgE to staphylococcal enterotoxins are undetectable in sera from patients with nasal polyposis 91
Diagnosis and Management of Allergic Rhinitis in Asthmatic Children 91
Biologic Therapy in a Patient with Asthma and Nasal Polyps 90
Anaphylaxis due to antiallergic and antiasthmatic biologics 89
Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry 89
The degree of serological sensitization to cat allergen in patients with or without cat at home 89
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments 88
Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database 88
Immunoblotting study of specific antibody patterns against latex and banana 87
Targeting eosinophils: severe asthma and beyond 87
One year of mepolizumab. Efficacy and safety in real-life in Italy 87
Oral health in asthmatic patients: a review: Asthma and its therapy may impact on oral health 87
How far from correct is the use of adrenaline auto-injectors? A survey in Italian patients 86
Component resolved diagnosis (CRD): how much is it presently used by Italian allergists? 85
Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity 85
The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors 84
Treatment with American Polistes venom was ineffective in an Italian patient allergic to European Polistes 84
Serum periostin during omalizumab therapy in asthma: A tool for patient selection and treatment evaluation 84
BCG vaccination and COVID-19: Much ado about nothing? 84
Effect of α1 Antitrypsin Deficiency on Lung Volume Decline in Severe Asthmatic Patients Undergoing Biologic Therapy 84
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 84
Totale 11.840
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.378
article - articoli 59.298
book - libri 463
conference - conferenze 235
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 382
Totale 120.756
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021228 0 0 0 0 0 71 17 31 21 8 50 30
2021/2022712 85 172 19 45 16 14 15 48 50 13 51 184
2022/20231.855 139 158 190 266 179 421 31 108 222 15 86 40
2023/20241.347 52 95 121 169 115 283 89 63 20 59 192 89
2024/20253.211 160 182 152 447 124 100 119 255 499 237 264 672
2025/20267.059 689 642 726 1.745 2.663 594 0 0 0 0 0 0
Totale 15.942